Efficacy of alemtuzumab in relapsing-remitting multiple sclerosis patients who relapsed on prior therapy (CARE-MSII): Subgroup analyses by previous DMT use

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2012
This article has no abstract
Epistemonikos ID: 0255b7f2e5513accfe8de3c3e18323b968bea5bc
First added on: Apr 30, 2026